4.0 Article

MicroRNAs in pathogenesis of breast cancer: Implications in diagnosis and treatment

Journal

WORLD JOURNAL OF CLINICAL ONCOLOGY
Volume 5, Issue 2, Pages 48-60

Publisher

BAISHIDENG PUBLISHING GROUP INC
DOI: 10.5306/wjco.v5.i2.48

Keywords

MicroRNAs; Breast cancer; Cancer stem cells; Diagnostic markers; Drug resistance

Categories

Funding

  1. American Cancer Society Research Award [RSG-10-067-01-TBE]
  2. NIH [1R01CA178386]

Ask authors/readers for more resources

MicroRNAs (miRNAs) are small non-coding RNAs generated by a two-step complex process and are post transcriptional negative regulators of their target mRNAs. Dysregulation of many of these miRNAs has been associated with tumorigenesis in various cancers including breast cancer. Aberrantly high expression of specific miRNAs in breast cancer cells is demonstrated to be linked with inhibition of tumor suppressor genes and promote tumorigenesis. They are classified as oncogenic miRNAs. However, the tumor suppressor miRNAs are downregulated in breast cancer cells, since their major targets are oncogenic mRNAs. Understanding mechanism of action of specific miRNAs in breast cancer cells can be utilized to develop newer anti-cancer therapies. Recently, newer techniques are also developed to detect abundance of specific miRNA in the blood plasma samples and can be used in early diagnosis or prognosis in breast cancer. In this review article, we have discussed several miRNAs dysregulated in breast cancer and their therapeutic potential. (C) 2014 Baishideng Publishing Group Co., Limited. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available